BECTON, DICKINSON AND COMPANY

Lobbying for BECTON DICKINSON AND COMPANY

Filing 2nd Quarter - Report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 20, 2026

Expenses

$622,000.00

What this organization spent lobbying with its own staff. Reported using C: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

District of Columbia

Official filing document

Government bodies contacted 10

Centers For Disease Control & Prevention (CDC)
Centers For Medicare and Medicaid Services (CMS)
Commerce, Dept of (DOC)
Health & Human Services, Dept of (HHS)
HOUSE OF REPRESENTATIVES
Office of Management & Budget (OMB)
SENATE
State, Dept of (DOS)
U.S. Trade Representative (USTR)
White House Office

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 5

Medicare/Medicaid

Issues related to reimbursement Issues related to CY2026 Home Health and DMEPOS PPS final rule and ANPRM on PPE and essential medicines

Health Issues

Issues related to medical technology regulation Issues related to medical device supply chains and supply chain resiliency Issues related to medical device sterilization Issues related to maternal health

Taxation/Internal Revenue Code

Issues related to corporate taxation Tax incentives for domestic manufacturing

Budget/Appropriations

Issues related to medical device supply chains and supply chain resiliency Issues related to medical device sterilization Issues related to the National Defense Authorization Act

Trade (domestic/foreign)

Issues related to international trade Issues related to medical device supply chain & Section 232 National Security Investigation into medical devices, and USMCA and Section 301 Investigations

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.